Post-authorization safety studies (PASS): can routinely collected data be used to identify side effects of drugs?
What is the purpose of PASSs? How to design a PASS? What is the impact of PASSs? Can we do more than just PASSs to exploit routine health data to examine for side effects of drugs?
You want to learn more? Attend the DSFE annual meeting 2022.
Time and venue
The meeting take place 1/11/2022 9.30-16.00 in Copenhagen at Danish Cancer Society Research Center. Please sign up by sending an email to email@example.com, no later than October 10th.
Would you like to give a 10 minute oral presentation of your pharmacoepidemiological research? Please submit your abstract no later than September 26th to firstname.lastname@example.org. UPDATE 6/10: Deadline for abstract submission extended to 6/10 (You will get notified no later than 10/10)
You can find the programme, description of the presenters, and abstract submission guidelines in this pdf
Slides from presentations
We thank the presenters for thier excellent presentations. The following slides from the presentations has been made available by the presenters:
|Purpose and impact of PASS||Susana Perez-Gutthann||Presentation|
|Development of PASS||Espen Jimenez Solem||Presentation|
|Hypothesis-free screening of adverse drug reaction in big data||Jesper Hallas||Presentation|